THIS ORDER LAYS DOWN THE REGULATORY BASES FOR TWO AID MEASURES AIMED AT DIRECTLY COMBATING THE EFFECTS OF INFECTION CAUSED BY SARS-COV-2 VIRUS. ON THE ONE HAND, A FIRST MEASURE IS ESTABLISHED CONSISTING OF PROMOTING RESEARCH AND DEVELOPMENT ACTIONS THAT CARRY OUT RESEARCH RELATED TO COVID-19, AS WELL AS OF THURSDAY, JULY 2, 2020 22180 NUMBER 127 RELEVANT PROCESS INNOVATIONS WITH A VIEW TO THE EFFICIENT PRODUCTION OF THE PRODUCTS NECESSARY FOR THEIR CONTAINMENT. ON THE OTHER HAND, THE AIM IS TO ENCOURAGE INVESTMENT IN THE MANUFACTURE OF COVID-19-RELATED PRODUCTS, MEDICINES, RAW MATERIALS FOR MEDICINES, PROTECTION SYSTEMS, COMPONENTS FOR THESE SYSTEMS, ETC.), AS WELL AS TESTING AND SCALING-UP INFRASTRUCTURES.